Tear Lipid Layer Thickness Assessments With Perfluorohexyloctane Eye Drops
Palo Alto (17 mi)Overseen byJennifer Fogt, OD MS
Age: 18+
Sex: Any
Travel: May be covered
Time Reimbursement: Varies
Trial Phase: N/A
Waitlist Available
Sponsor: Ohio State University
No Placebo Group
Trial Summary
What is the purpose of this trial?The purpose of this study is to explore the tear lipid layer quantitatively and qualitatively before and after use of a perflurohexyloctane eye drop (NovaTears)
Eligibility Criteria
Treatment Details
1Treatment groups
Experimental Treatment
Group I: Perfluorohexyloctane eye dropExperimental Treatment1 Intervention
Participants will have their tear lipid layer assessed. They will then have the eye drop instilled and will have an additional assessment of the tear lipid layer within 5 minutes of instillation of the the drop, and again 15 minutes after instillation.
Find a clinic near you
Research locations nearbySelect from list below to view details:
The Ohio State University College of OptometryColumbus, OH
Loading ...
Who is running the clinical trial?
Ohio State UniversityLead Sponsor